Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies

Hany E Marei; Carlo Cenciarelli

doi:10.3390/biomedicines11020627

Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies

Biomedicines. 2023 Feb 20;11(2):627. doi: 10.3390/biomedicines11020627.

Authors

Hany E Marei¹, Carlo Cenciarelli²

Affiliations

¹ Department of Cytology and Histology, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35116, Egypt.
² Institute of Translational Pharmacology (IFT)-CNR, 00133 Rome, Italy.

Abstract

Given that CAR-T cell therapy is effective in CD19-positive blood malignancies, it offers great hope for a variety of aggressive tumors that have thus far shown very little response to available therapies [...].

Publication types

Editorial

Grants and funding

This research received no external funding.